Diagnostics & Stewardship

In vitro diagnostic tests play an essential role in combatting the Antibiotic Resistance threat. Our extensive Antimicrobial Stewardship (AMS) diagnostics offer supports appropriate antibiotic use, helping to preserve their efficacy and curb antibiotic resistance. 

It’s about having the right diagnostic tool to provide timely, relevant antimicrobial therapy information in every situation. See what just some of our AMS Diagnostic Solutions can do for you:

1. Deol P. et al. 2016; 26th ECCMID #EVO459

2. Lovern D., et al. Eur J Clin Microbiol Infect Dis., Dec 2016.

3. Rommler W., et al. Poster C-123, ASM Orlando, May 2006

4. Meisner M., et al. J Lab Med 1999;23:263-72

5. Schuetz P., et al. Crit care Med 2017 ; 45(5):781-789

6. Bouadma L., et al. Lancet 2010;375: DOI:10.1016/S0140-6736(09)61879-1 

7. De Jong A., et al. The Lancet Infectious Diseases 2016 ; 16(7):819-827

8. Schuetz P., et al. Arch Intern Med 2011;171:1322-1331

BACT/ALERT® VIRTUO®, an automated instrument for faster blood culture

  • Fast & actionable results: Gain 4 hours on average
  • Avoid unnecessary patient treatment & supplementary testing: Improved sensitivity and specificity
  • Real-time notifications: Specific retrieval of positive bottles plus visual and audible alerts

VITEK® 2, an automated identification and antibiotic susceptibility testing analyzer

  • Same day results: in as little as 5 hours  with customized reporting possible
  • Keep pace with pathogen evolution: regular updates of antibiotic breakpoints, and organism phenotypes


VIDAS® B.R.A.H.M.S PCT™, automated test to determine procalcitonin (PCT), a specific marker of severe bacterial infection and sepsis

  • Emergency situations: 20-minute results
  • Earlier antibiotic therapy: PCT levels detectable 3 – 6 hours after infectious challenge
  • Useful therapy information: antibiotic therapy monitoring - continue or stop antibiotics
  • Proven to be clinically useful for antibiotic stewardship: Sepsis and LRTI



VITEK® MS, Mass spectrometry microbial identification system

  • More specific treatment: Single choice identifications at the species, genus or group level
  • Rapid results: A few minutes is all it takes
  • Better discrimination between species: Report results based on a population-built database to cover most of your routine needs

BIOFIRE® FILMARRAY® PANELS, for syndromic testing with multiplex PCR system

  • Faster results: Approximately 1 hour for syndromic results of multitude of likely pathogens
  • Faster initiation of correct treatment: Increased capacity to detect co-infections
  • Less delay in processing samples: Easy to use by any technician at any time to increase emergency coverage to 24/7






Future generations need us to sustain antibiotic efficacy and curb resistance. As a healthcare professional, you know that appropriate use of antibiotics is key.

Put diagnostics at the heart of AMS to drive informed therapy decisions. From antibiotic initiation, to optimization, to discontinuation, trust bioMérieux diagnostic solutions. Like you, we are for advancing antimicrobial stewardship.

Educational Resources

Join Dr. Laurent Poirel, University of Fribourg, Switzerland, a leading expert on Carbapenem Resistance, and discover the latest in new diagnostic technologies for fast detection and identification of Carbapenemase-producing Gram-negative organisms.

Rapid Diagnostics of Carbapenemase-producing Organisms

Dr. Laurent Poirel, PhD
(Co-creator of the original Carba NP test)

November 13, 2018  -  
1:00 PM EST

Tune in!

Learn more about Antimicrobial Resistance on bioMérieux’s dedicated website.


bioMérieux has developed a collection of educational booklets on key Diagnostics/Healthcare topics. We invite you to download the selection below !

Read more!


A practical guide to implementation in hospitals


Optimization through Drug Dosing and MIC

Let’s combine our skills further to sustain antibiotics for future generations!

Copyright bioMérieux 2018

Follow us: